Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Regular Articles
Bootstrap Resampling Technique to Evaluate the Reliability of the Optimal Liposome Formulation: Skin Permeability and Stability Response Variables
Sureewan DuangjitPraneet OpanasopitTheerasak RojanarataJun TakayamaKozo TakayamaTanasait Ngawhirunpat
Author information
JOURNALS FREE ACCESS FULL-TEXT HTML

2014 Volume 37 Issue 9 Pages 1543-1549

Details
Abstract

A nonlinear response surface method incorporating multivariate spline interpolation (RSM-S) is a useful technique for the optimization of pharmaceutical formulations, although the direct reliability of the optimal formulation must be evaluated. In this study, we demonstrated the feasibility of using the bootstrap (BS) resampling technique to evaluate the direct reliability of the optimal liposome formulation predicted by RSM-S. The formulation characteristics (Xn), including vesicle size (X1), size distribution (X2), zeta potential (X3), elasticity (X4), drug content (X5), entrapment efficiency (X6), release rate (X7), and the penetration enhancer (PE) factors as formulation factors (Zn), with the type of PE (Z1) and content of PE (Z2) were used as causal factors of the response surface analysis. The intended responses were high skin permeability (flux, Y1) and high stability formulation (drug remaining, Y2). Based on the dataset obtained, the simultaneous optimal solutions were estimated using RSM-S. Leave-one-out-cross-validation showed satisfying reliability of the optimal solution. Concurrently, similar BS optimal solutions were estimated from the BS dataset that was generated from the original dataset through BS resampling at frequencies of 250, 500, 750, and 1000. The analysis and simulation indicated that X4, X5, and Z2 were the prime factors affecting Y1 and Y2. These findings suggest that this approach could also be useful for evaluating the reliability of an optimal liposome formulation predicted by RSM-S and would be beneficial for the pharmaceutical development of liposomes for transdermal drug delivery.

Information related to the author
© 2014 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top